Browsing Barts Cancer Institute by Title

Variable Penetrance Is Linked with Monoallelic Gene Expression in Inherited GATA2-Mutated MDS/AML

Al Seraihi, A; Rio-Machin, A; Tawana, K; Boedoer, C; Araf, S; Heward, JA; Smith, M; Iqbal, S; Best, S; Lea, N (2016-12-02)

Variation in the management of ductal carcinoma in situ in the UK: Results of the Mammary Fold National Practice Survey

Bathla, S; Fatayer, H; Sirianni, C; Ashken, L; Khan, SM; Hignett, S; Rathinaezhil, R; Thomas, H; Isherwood, J; Topps, A (2016-08)

Variation in the outcome reported by studies of fertility-sparing interventions for atypical endometrial hyperplasia and early endometrial cancer: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets)

Tan, A; Rivas, C; Yorke, S; Khan, K; Brockbank, E; Manchanda, R; Cooper, N (2019-06)

Variation in the outcome reported by studies of interventions for atypical endometrial hyperplasia: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets)

Tan, A; Rivas, C; Yorke, S; Khan, K; Rogozinska, E; Brockbank, E; Manchanda, R; Cooper, N (2019-06)

Variation in the outcome reported by studies of interventions for endometrial cancer: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets)

Tan, A; Rivas, C; Yorke, S; Khan, K; Brockbank, E; Manchanda, R; Cooper, N (2019-06)

Variations in gynecologic oncology training in low (LIC) and middle income (MIC) countries (LMICs): Common efforts and challenges.

Johnston, C; Ng, JS; Manchanda, R; Tsunoda, AT; Chuang, L (2017-05)

Gynecologic cancer, cervical cancer in particular, is disproportionately represented in the developing world where mortality is also high. Screening programs, increased availability of chemotherapy, and an awareness of ...

Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma

Passalidou, E; Stewart, M; Trivella, M; Steers, G; Pillai, G; Dogan, A; Leigh, I; Hatton, C; Harris, A; Gatter, K (2003-02-24)

Venetoclax-based low intensity therapy in molecular failure of NPM1 mutated AML.

Chillon, CJ; Othman, J; Taussig, D; Jiménez-Vicente, C; Martínez-Roca, A; Tiong, IS; Jain, M; Aries, J; Cakmak, S; Knapper, S (2023-12-01)

Molecular failure in NPM1 mutated AML inevitably progresses to frank relapse if untreated. Recently published small case series show that venetoclax combined with low dose cytarabine or azacitidine can reduce or eliminate ...

A Virus-Infected, Reprogrammed Somatic Cell-Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic Cancer

Lu, S; Zhang, Z; Du, P; Chard, LS; Yan, W; El Khouri, M; Wang, Z; Zhang, Z; Chu, Y; Gao, D (2020-01-15)